Categories U.S. Markets News

FDA adds restrictions on sale of e-cigarettes

The US Food and Drug Administration (FDA) is bringing new restrictions to the sale of e-cigarettes to put an end to the “alarming” increase in vaping among teenagers. According to data collected by the agency, there was a 78% increase in vaping among high school students and a 48% increase among middle school students.

Sale of flavored e-cigarettes, except menthol, will be banned at places where the under-aged can purchase them. According to the FDA data, over 3.6 million school students currently use e-cigarettes.

e-cigarette restriction FDA
Courtesy: Wikimedia Commons

The move comes two months after the FDA Commissioner Scott Gottlieb tasked the cigarette makers to come up with an action plan to reduce addiction among teenagers. Altria (MO), British American Tobacco, Imperial Brands, and Japan Tobacco were asked to submit reports on the same before November 11.

Gottlieb has also set certain policies for the sale of these products, which, if violated, may lead to the products being pulled out of stores.

Altria shares were down 1.9% during intra-day trading following the announcement. Meanwhile, peer tobacco company Philip Morris International (PM) was almost flat on Thursday. Both companies have been hit hard by the crackdown on cigarette consumption by the FDA. During the past 52 weeks, Altria shares have been down 10.7%, while PM is down 16%.

Manufacturers who wish to sell flavored e-cigarettes in the future will now need to get it tested and authorized by the FDA. Gottlieb added that the products that are currently available in the market will also see a round of testing.

Altria was the first to respond to FDA’s latest requirements. The company said it would remove MarkTen pod-based products and would stop selling flavored products.

 

Get access to timely and accurate verbatim transcripts that are published within hours of the event

Most Popular

CL Earnings: Key quarterly highlights from Colgate-Palmolive Company’s Q4 2022 financial results

Colgate-Palmolive Company (NYSE: CL) reported fourth quarter 2022 earnings results today. Net sales increased 5% year-over-year to $4.62 billion. Organic sales growth was 8.5%. Net income attributable to Colgate-Palmolive Company was

Key highlights from Chevron Corporation’s (CVX) Q4 2022 earnings results

Chevron Corporation (NYSE: CVX) reported fourth quarter 2022 earnings results today. Total revenues and other income were $56.4 billion compared to $48.1 billion in the year-ago period. Net income attributable

AXP Earnings: All you need to know about American Express’ Q4 2022 earnings results

American Express Company (NYSE: AXP) reported fourth quarter 2022 earnings results. Consolidated total revenues net of interest expense were $14.2 billion, up 17% from a year ago. Net income was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top